Evaluating the Clinical Performance of SDC2/NDRG4 Methylation for Colorectal Cancer Detection

References

• Dekker E , Tanis PJ , Vleugels JLA , Kasi PM , Wallace MB . Colorectal cancer. Lancet 394(10207), 1467–1480 (2019).
   PubMed Web of Science ®Google Scholar
• Sung H , Ferlay J , Siegel RL et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71(3), 209–249 (2021).
   PubMed Web of Science ®Google Scholar
• Yin Z , Yao C , Zhang L , Qi S . Application of artificial intelligence in diagnosis and treatment of colorectal cancer: a novel prospect. Front. Med. (Lausanne) 10, 1128084 (2023).
   PubMed Web of Science ®Google Scholar
• Nfonsam V , Wusterbarth E , Gong A , Vij P . Early-onset colorectal cancer. Surg. Oncol. Clin. N. Am. 31(2), 143–155 (2022).
   PubMed Web of Science ®Google Scholar
• Simon K . Colorectal cancer development and advances in screening. Clin. Interv. Aging 11, 967–976 (2016).
   PubMed Web of Science ®Google Scholar
• Muller D , Gyorffy B . DNA methylation-based diagnostic, prognostic, and predictive biomarkers in colorectal cancer. Biochim. Biophys. Acta Rev. Cancer 1877(3), 188722 (2022).
   PubMed Web of Science ®Google Scholar
• Eng C , Jacome AA , Agarwal R et al. A comprehensive framework for early-onset colorectal cancer research. Lancet Oncol. 23(3), e116–e128 (2022).
   PubMed Web of Science ®Google Scholar
• Anghel SA , Ionita-Mindrican CB , Luca I , Pop AL . Promising epigenetic biomarkers for the early detection of colorectal cancer: a systematic review. Cancers (Basel) 13(19), (2021).
   PubMed Web of Science ®Google Scholar
• Chen J , Sun H , Tang W et al. DNA methylation biomarkers in stool for early screening of colorectal cancer. J. Cancer 10(21), 5264–5271 (2019).
   PubMed Web of Science ®Google Scholar
• Ruiz XD , Mlakar LR , Yamaguchi Y et al. Syndecan-2 is a novel target of insulin-like growth factor binding protein-3 and is over-expressed in fibrosis. PLOS ONE 7(8), e43049 (2012).
   PubMed Web of Science ®Google Scholar
• Lee H , Kim Y , Choi Y , Choi S , Hong E , Oh ES . Syndecan-2 cytoplasmic domain regulates colon cancer cell migration via interaction with syntenin-1. Biochem. Biophys. Res. Commun. 409(1), 148–153 (2011).
   PubMed Web of Science ®Google Scholar
• Han I , Park H , Oh ES . New insights into syndecan-2 expression and tumourigenic activity in colon carcinoma cells. J. Mol. Histol. 35(3), 319–326 (2004).
   PubMed Web of Science ®Google Scholar
• de Klaver W , Wisse PHA , van Wifferen F et al. Clinical validation of a multitarget fecal immunochemical test for colorectal cancer screening: a diagnostic test accuracy study. Ann. Intern. Med. 174(9), 1224–1231 (2021).
   PubMed Web of Science ®Google Scholar
• Han YD , Oh TJ , Chung TH et al. Early detection of colorectal cancer based on presence of methylated syndecan-2 (SDC2) in stool DNA. Clin. Epigenetics 11(1), 51 (2019).
   PubMedGoogle Scholar
• Zhang W , Yang C , Wang S et al. SDC2 and TFPI2 methylation in stool samples as an integrated biomarker for early detection of colorectal cancer. Cancer Manag. Res. 13, 3601–3617 (2021).
   PubMed Web of Science ®Google Scholar
• Oh TJ , Oh HI , Seo YY et al. Feasibility of quantifying SDC2 methylation in stool DNA for early detection of colorectal cancer. Clin. Epigenetics 9, 126 (2017).
   PubMed Web of Science ®Google Scholar
• Zhou RH , Kokame K , Tsukamoto Y , Yutani C , Kato H , Miyata T . Characterization of the human NDRG gene family: a newly identified member, NDRG4, is specifically expressed in brain and heart. Genomics 73(1), 86–97 (2001).
   PubMed Web of Science ®Google Scholar
• Qu X , Jia H , Garrity DM et al. Ndrg4 is required for normal myocyte proliferation during early cardiac development in zebrafish. Dev. Biol. 317(2), 486–496 (2008).
   PubMed Web of Science ®Google Scholar
• Melotte V , Lentjes MH , van den Bosch SM et al. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer. J. Natl Cancer Inst. 101(13), 916–927 (2009).
   PubMed Web of Science ®Google Scholar
• Chu D , Zhang Z , Zhou Y et al. NDRG4, a novel candidate tumor suppressor, is a predictor of overall survival of colorectal cancer patients. Oncotarget 6(10), 7584–7596 (2015).
   PubMedGoogle Scholar
• Zeng H , Chen K , Ma C et al. High-throughput primer design by scoring in piecewise logistic model for multiple polymerase chain reaction variants. Sci. Rep. 12(1), 21136 (2022).
   PubMed Web of Science ®Google Scholar
• Casey Y , Demb J , Enwerem N et al. Risk of incident and fatal colorectal cancer after young-onset adenoma diagnosis: a national cohort study. Am. J. Gastroenterol. doi: 10.14309/ajg.0000000000002296 (2023).
   PubMed Web of Science ®Google Scholar
• Wu Z , Li Y , Zhang Y et al. Colorectal cancer screening methods and molecular markers for early detection. Technol. Cancer Res. Treat. 19, 1533033820980426 (2020).
   Web of Science ®Google Scholar
• Saraiva MR , Rosa I , Claro I . Early-onset colorectal cancer: A review of current knowledge. World J. Gastroenterol. 29(8), 1289–1303 (2023).
   PubMed Web of Science ®Google Scholar
• Collaborative R , Zaborowski AM , Abdile A et al. Characteristics of early-onset vs late-onset colorectal cancer: a review. JAMA Surg. 156(9), 865–874 (2021).
   PubMed Web of Science ®Google Scholar
• Colorectal Cancer Screening (PDQ(R)): Health Professional Version. In: PDQ Cancer Information Summaries. MD, USA (2002).
   Google Scholar
• Hanna M , Dey N , Grady WM . Emerging tests for noninvasive colorectal cancer screening. Clin. Gastroenterol. Hepatol. 21(3), 604–616 (2023).
   PubMed Web of Science ®Google Scholar
• Bresalier RS . Colorectal cancer screening in a changing world. Gastroenterol. Clin. North Am. 51(3), 577–591 (2022).
   PubMed Web of Science ®Google Scholar
• Jin X , Cai C , Zhao J et al. Opportunistic colonoscopy in healthy individuals: a non-trivial risk of adenoma. PLOS ONE 18(4), e0283575 (2023).
   PubMed Web of Science ®Google Scholar
• Luk GD , Desai TK , Conteas CN , Moshier JA , Silverman AL . Biochemical markers in colorectal cancer: diagnostic and therapeutic implications. Gastroenterol. Clin. North Am. 17(4), 931–940 (1988).
   PubMed Web of Science ®Google Scholar
• Kijima S , Sasaki T , Nagata K , Utano K , Lefor AT , Sugimoto H . Preoperative evaluation of colorectal cancer using CT colonography, MRI, and PET/CT. World J. Gastroenterol. 20(45), 16964–16975 (2014).
   PubMed Web of Science ®Google Scholar
• Pickhardt PJ , Choi JR , Hwang I et al. Computed tomographic virtual colonoscopy to screen for colorectal neoplasia in asymptomatic adults. N. Engl. J. Med. 349(23), 2191–2200 (2003).
   PubMed Web of Science ®Google Scholar
• Imperiale TF , Ransohoff DF , Itzkowitz SH . Multitarget stool DNA testing for colorectal-cancer screening. N. Engl. J. Med. 371(2), 187–188 (2014).
   PubMedGoogle Scholar
• Robertson DJ , Imperiale TF . Stool testing for colorectal cancer screening. Gastroenterology 149(5), 1286–1293 (2015).
   PubMed Web of Science ®Google Scholar
• Ding Q , Kong X , Zhong W , Liu W . Fecal biomarkers: Non-invasive diagnosis of colorectal cancer. Front. Oncol. 12, 971930 (2022).
   PubMed Web of Science ®Google Scholar
• Kamel F , Eltarhoni K , Nisar P , Soloviev M . Colorectal cancer diagnosis: the obstacles we face in determining a non-invasive test and current advances in biomarker detection. Cancers (Basel) 14(8), (2022).
   Web of Science ®Google Scholar
• Imperiale TF , Ransohoff DF , Itzkowitz SH et al. Multitarget stool DNA testing for colorectal-cancer screening. N. Engl. J. Med. 370(14), 1287–1297 (2014).
   PubMed Web of Science ®Google Scholar
• Lu H , Huang S , Zhang X et al. DNA methylation analysis of SFRP2, GATA4/5, NDRG4 and VIM for the detection of colorectal cancer in fecal DNA. Oncol. Lett. 8(4), 1751–1756 (2014).
   PubMed Web of Science ®Google Scholar
• Ahlquist DA , Zou H , Domanico M et al. Next-generation stool DNA test accurately detects colorectal cancer and large adenomas. Gastroenterology 142(2), 248–256; quiz e225-246 (2012).
   PubMed Web of Science ®Google Scholar
• Wang J , Liu S , Wang H et al. Robust performance of a novel stool DNA test of methylated SDC2 for colorectal cancer detection: a multicenter clinical study. Clin. Epigenetics 12(1), 162 (2020).
   PubMed Web of Science ®Google Scholar
• Wang Z , Shang J , Zhang G et al. Evaluating the clinical performance of a dual-target stool DNA test for colorectal cancer detection. J. Mol. Diagn. 24(2), 131–143 (2022).
   PubMed Web of Science ®Google Scholar
• Hibi K , Goto T , Shirahata A et al. Detection of TFPI2 methylation in the serum of gastric cancer patients. Anticancer Res. 31(11), 3835–3838 (2011).
   PubMed Web of Science ®Google Scholar
• Ma L , Gong J , Zhao M et al. A novel stool methylation test for the non-invasive screening of gastric and colorectal cancer. Front. Oncol. 12, 860701 (2022).
   PubMed Web of Science ®Google Scholar
• Bartak BK , Fodor T , Kalmar A et al. A liquid biopsy-based approach for monitoring treatment response in post-operative colorectal cancer patients. Int. J. Mol. Sci. 23(7), 3774 (2022).
   PubMed Web of Science ®Google Scholar
• Jin S , Zhu D , Shao F et al. Efficient detection and post-surgical monitoring of colon cancer with a multi-marker DNA methylation liquid biopsy. Proc. Natl Acad. Sci. USA 118(5), e2017421118 (2021).
   PubMed Web of Science ®Google Scholar